 The stock price of Cassava Sciences plunged 23 yesterday after a report that the U.S. SEC is investigating the company over allegations of data manipulation for its experimental Alzheimers treatment - Simufilam. 1 SAVA stock saw a large fall in September following a citizen petition filed to. 